SecBot SecBot
SECBOTREPLAY Home › Report › CABA

CABA · Cabaletta Bio priced a $150M underwritten offering of 51.7M shares at…

Cabaletta Bio, Inc. · 8-K filed May 4, 2026 at 06:40 ET

At the news

BEARISHIMPACT 7/10

8-K filed May 4, 2026 at 06:40 ET

Cabaletta Bio priced a $150M underwritten offering of 51.7M shares at $2.90/share, representing ~51% dilution from the prior ~100.5M shares outstanding. The filing also disclosed a preliminary cash balance of ~$117M as of March 31, 2026, and the company reported Q4 2025 EPS of -$0.40, a 3.1% miss vs consensus of -$0.39. The capital raise extends the cash runway into mid-2027 to fund clinical development of rese-cel, but the massive dilution and lack of revenue fundamentally overshadow the pipeline progress.

  • Priced underwritten offering of 51,725,000 shares at $2.90 per share, raising ~$150M in gross proceeds (~$141M net)
  • Offering represents ~51% increase in shares outstanding from ~100.5M to ~152.2M shares
  • Q4 2025 EPS of -$0.40 missed consensus of -$0.39 by 3.1%
  • Preliminary cash balance of ~$117M as of March 31, 2026

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access